As a leading healthcare innovator, Johnson & Johnson in Switzerland is in a unique position to shape the future of healthcare.
From the acquisition of Cilag AG in 1959 to other major acquisitions such as Crucell, Synthes GmbH and Actelion Pharmaceuticals, we have always been determined to improve health through innovation. This has led us to the influential footprint that we have in Switzerland today.
From R&D to manufacturing and commercial, the end-to-end value chain of our MedTech and Innovative Medicine sectors is represented in Switzerland across 9 sites and with around 5600 employees.
As the science of human health and well-being has grown, we’ve been able to grow with it. Even more important, we’ve helped shape and define what health and well-being means in our everyday lives. Our products, services and ideas now touch the lives of at least one billion people every day. We credit our strength and endurance to a consistent approach to managing our business and to the character of our people.
We are committed to providing a workplace that treats our employees with respect and dignity – a place where our employees are empowered to be, feel and do their best every day.
Giving back and supporting the communities where we work and live is called out as a key priority in Our Credo and part of Johnson & Johnson’s DNA. We started this long before the words “citizenship” and “corporate social responsibility” were fashionable. For us, this is a calling and not just a business.